N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2) Peptid
NAT2
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN937133
382,12 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 20 bis 27 Werktagen
Kurzübersicht für N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2) Peptid (ABIN937133)
Target
NAT2
(N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- CLTEERGIWY LDQIRREQYI TNKEFLNSHL LPKKKHQKIY LFTLEPRTIE
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of NAT2 antibody,
Alternative Names: NAT2 control peptide, NAT2 antibody Blocking Peptide, Anti-NAT2 Blocking Peptide, N-Acetyltransferase 2 Blocking Peptide, Arylamine N-Acetyltransferase Blocking Peptide, AAC2 Blocking Peptide, NAT2, NAT-2, NAT 2, NAT-2 Blocking Peptide, NAT 2 Blocking Peptide -
Aufreinigung
- The antibody is affinity-purified from rabbit antiserum by affinity chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide is removed by chromatogramphy using non-phosphopeptide corresponding to the phosphorylation site.
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- NAT2 (N-Acetyltransferase 2 (Arylamine N-Acetyltransferase) (NAT2))
-
Hintergrund
- NAT2 is a N-acetyltransferase 2 (arylamine N-acetyltransferase 2). This enzyme functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in its gene are reponsible for the N-acetylation polymorphism in which human populations segregate into rapid,intermediate, and slow acetylator phenotypes. Polymorphisms in NAT2 are also associated with higher incidences of cancer and drug toxicity.
-
Molekulargewicht
- 32 kDa
Target
-
Sie sind hier:
